In reference to the open label trial. is there a possibility that the groundbreaking data can be 'saved' for publication in a Journal? I tend to worry that it will be held back so that it can have the greatest impact, but further delaying an increase in SP appreciation. I go back to thinking, that we were hoping for some type of validation of FTO from Domissini and the Sheba trial. I suppose what I'm ultimately pondering is what will they actually report on, if all goes as you and I suspect?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.16 | $39.17K | 33.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3560 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 4359 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |